HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

European NSTEMI guidelines-return of clopidogrel?

AuthorsLisa Dannenberg, René M'Pembele, Daniel Metzen, Tobias Petzold, Tobias Zeus, Malte Kelm, Amin Polzin
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 78 Issue 1 Pg. 151-153 (Jan 2022) ISSN: 1432-1041 [Electronic] Germany
PMID34528121 (Publication Type: Letter)
Chemical References
  • P2RY12 protein, human
  • Platelet Aggregation Inhibitors
  • Receptors, Purinergic P2Y12
  • Clopidogrel
Topics
  • Clopidogrel (therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Myocardial Infarction (drug therapy)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Practice Guidelines as Topic
  • Receptors, Purinergic P2Y12
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: